UK markets close in 4 hours 34 minutes

Tapestry, Inc. (0LD5.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
39.84-0.41 (-1.02%)
As of 06:49PM BST. Market open.
Full screen
Previous close40.25
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's range0.00 - 0.00
52-week range
Volume21,500
Avg. volume11,480
Market cap116.783M
Beta (5Y monthly)1.60
PE ratio (TTM)0.13
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Tapestry, Inc. Responds to the FTC’s Lawsuit

    NEW YORK, April 22, 2024--Tapestry, Inc. (NYSE: TPR), a house of iconic accessories and lifestyle brands consisting of Coach, Kate Spade, and Stuart Weitzman, today issued the following statement in response to the Federal Trade Commission’s (FTC) attempt to block its proposed acquisition of Capri Holdings Limited (NYSE: CPRI), a global luxury fashion group consisting of Versace, Jimmy Choo, and Michael Kors:

  • GlobeNewswire

    Tapestry Expands Partnership With Bluecore to Include Kate Spade Following Success With Coach and Stuart Weitzman

    Bluecore’s Marketing Platform Drove Meaningful Customer Movement in 2023, Paving the Way for Growth and Retention in 2024NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Bluecore, a retail shopper identification and customer movement technology, has announced that its relationship with Tapestry (NYSE: TPR) is expanding across the brand portfolio to include its kate spade new york brand. The platform has been delivering strong identification improvements and contributing to marketing growth for Coach

  • Business Wire

    Tapestry, Inc. Appoints Kevin Hourican and David Elkins to Board of Directors

    NEW YORK, February 29, 2024--Tapestry, Inc. (NYSE: TPR), a house of iconic accessories and lifestyle brands consisting of Coach, Kate Spade, and Stuart Weitzman, today announced that Kevin Hourican, President and Chief Executive Officer of Sysco Corporation (NYSE: SYY), and David Elkins, Executive Vice President and Chief Financial Officer of Bristol Myers Squibb (NYSE: BMY), have been appointed to the Company’s Board of Directors. The appointments of Mr. Hourican and Mr. Elkins to the Board bri